IP Verse

Use Of Cannabinoids In The Treatment Of Epilepsy

Patent No. EP3206716 (titled "Use Of Cannabinoids In The Treatment Of Epilepsy") was filed by GW Pharma on Oct 14, 2015. The application was issued on Jul 29, 2020.

Patent Summary

Cannabidiol (CBD) is used for treating atonic seizures in patients with Lennox-Gastaut syndrome. The CBD must be administered either as a synthetic compound or as a highly purified cannabis extract containing at least 98% (w/w) CBD. The invention addresses treatment-resistant epilepsy, specifically targeting atonic seizures (drop attacks) characterized by brief loss of muscle tone. The CBD may be formulated in a composition comprising a solvent, co-solvent, sweetener, and flavoring. In clinical contexts, this treatment may be used concomitantly with anti-epileptic drugs (AEDs) such as clobazam, clonazepam, levetiracetam, topiramate, stiripentol, phenobarbital, lacosamide, valproic acid, zonisamide, perampanel, or fosphenytoin. The purified CBD demonstrates significant efficacy in reducing atonic seizure frequency in patients unresponsive to standard AED therapies.

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
JAMES POOLEApr 29, 2021CABINET BECKER ET ASSOCIES

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3206716

GW PHARMA
Application Number
EP15784111A
Filing Date
Oct 14, 2015
Status
Granted And Under Opposition
Jun 26, 2020
Publication Date
Jul 29, 2020
External Links
Slate, Register , Google Patents